Related Experiment Videos
Matrix metalloproteinase-9 regulates graft bone resorption.
1Department of Oral Health Sciences, Faculty of Dentistry, University of British Columbia, Vancouver, Canada.
The Angle Orthodontist
|July 1, 2006
Summary
Matrix metalloproteinase-9 (MMP-9) drives bone resorption in bone grafts. Autogenous endochondral bone grafts show higher MMP-9 levels and resorption compared to other graft types.
Area of Science:
- Biomaterials Science
- Surgical Innovation
- Oral and Maxillofacial Surgery
Background:
- Bone grafting is crucial for reconstructing bone defects.
- Understanding graft resorption mechanisms is vital for improving outcomes.
- Matrix metalloproteinase-9 (MMP-9) is implicated in tissue remodeling.
Purpose of the Study:
- To investigate the correlation between MMP-9 expression and bone resorption in different bone graft types.
- To elucidate the role of MMP-9 in the resorption process of autogenous and allogenic bone grafts.
Main Methods:
- Critical-size mandibular defects were created in rabbits.
- Grafts included autogenous endochondral (EC) bone, autogenous intramembranous (IM) bone, and allogenic IM bone.
- Histology, immunohistochemistry, and in situ hybridization were used for analysis.
Main Results:
- A strong association was observed between MMP-9 expression levels and the extent of graft bone resorption.
- Increased MMP-9 production was evident in preosteoclasts and osteoclasts during resorption.
- Autogenous EC bone grafts exhibited higher MMP-9 expression and resorption rates.
Conclusions:
- MMP-9 is a key mediator of bone resorption in bone grafts.
- Autogenous EC bone grafts undergo greater resorption due to higher MMP-9 expression compared to autogenous or allogenic IM grafts.
- Targeting MMP-9 could potentially modulate bone graft resorption.